0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 1,3-Diaminoguanidine Monohydrochloride Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-18O17203
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global 1 3 Diaminoguanidine Monohydrochloride Market Research Report 2024
BUY CHAPTERS

Global 1,3-Diaminoguanidine Monohydrochloride Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-18O17203
Report
November 2025
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

1,3-Diaminoguanidine Monohydrochloride Market

The global 1,3-Diaminoguanidine Monohydrochloride market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Pesticide Intermediates accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
1,3-Diaminoguanidine Monohydrochloride leading manufacturers including Sajjan India Limited, Shandong Winner Biotech, Suzhou Senfida Chemica, Jinan Aodekai Pharmaceutical, Huaihua Wangda Biotechnology, Jinhua Qianjiang Fine Chemical, etc., dominate supply; the top five capture approximately % of global revenue, with Sajjan India Limited leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global 1,3-Diaminoguanidine Monohydrochloride market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of 1,3-Diaminoguanidine Monohydrochloride Market Report

Report Metric Details
Report Name 1,3-Diaminoguanidine Monohydrochloride Market
Segment by Type
  • Purity 99%
  • Purity 98%
  • Others
Segment by Application
  • Pesticide Intermediates
  • Pharmaceutical Intermediates
  • Others
Production by Region
  • China
  • India
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sajjan India Limited, Shandong Winner Biotech, Suzhou Senfida Chemica, Jinan Aodekai Pharmaceutical, Huaihua Wangda Biotechnology, Jinhua Qianjiang Fine Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the 1,3-Diaminoguanidine Monohydrochloride study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the 1,3-Diaminoguanidine Monohydrochloride Market report?

Ans: The main players in the 1,3-Diaminoguanidine Monohydrochloride Market are Sajjan India Limited, Shandong Winner Biotech, Suzhou Senfida Chemica, Jinan Aodekai Pharmaceutical, Huaihua Wangda Biotechnology, Jinhua Qianjiang Fine Chemical

What are the Application segmentation covered in the 1,3-Diaminoguanidine Monohydrochloride Market report?

Ans: The Applications covered in the 1,3-Diaminoguanidine Monohydrochloride Market report are Pesticide Intermediates, Pharmaceutical Intermediates, Others

What are the Type segmentation covered in the 1,3-Diaminoguanidine Monohydrochloride Market report?

Ans: The Types covered in the 1,3-Diaminoguanidine Monohydrochloride Market report are Purity 99%, Purity 98%, Others

1 Study Coverage
1.1 Introduction to 1,3-Diaminoguanidine Monohydrochloride: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global 1,3-Diaminoguanidine Monohydrochloride Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity 99%
1.2.3 Purity 98%
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global 1,3-Diaminoguanidine Monohydrochloride Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pesticide Intermediates
1.3.3 Pharmaceutical Intermediates
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global 1,3-Diaminoguanidine Monohydrochloride Revenue Estimates and Forecasts 2020-2031
2.2 Global 1,3-Diaminoguanidine Monohydrochloride Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global 1,3-Diaminoguanidine Monohydrochloride Sales Estimates and Forecasts 2020-2031
2.4 Global 1,3-Diaminoguanidine Monohydrochloride Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global 1,3-Diaminoguanidine Monohydrochloride Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 China
3.4.2 India
4 Competition by Manufacturers
4.1 Global 1,3-Diaminoguanidine Monohydrochloride Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global 1,3-Diaminoguanidine Monohydrochloride Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity 99% Market Size by Manufacturers
4.5.2 Purity 98% Market Size by Manufacturers
4.5.3 Others Market Size by Manufacturers
4.6 Global 1,3-Diaminoguanidine Monohydrochloride Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global 1,3-Diaminoguanidine Monohydrochloride Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global 1,3-Diaminoguanidine Monohydrochloride Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global 1,3-Diaminoguanidine Monohydrochloride Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global 1,3-Diaminoguanidine Monohydrochloride Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America 1,3-Diaminoguanidine Monohydrochloride Sales and Revenue by Type (2020-2031)
7.4 North America 1,3-Diaminoguanidine Monohydrochloride Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America 1,3-Diaminoguanidine Monohydrochloride Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe 1,3-Diaminoguanidine Monohydrochloride Sales and Revenue by Type (2020-2031)
8.4 Europe 1,3-Diaminoguanidine Monohydrochloride Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe 1,3-Diaminoguanidine Monohydrochloride Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America 1,3-Diaminoguanidine Monohydrochloride Sales and Revenue by Type (2020-2031)
10.4 Central and South America 1,3-Diaminoguanidine Monohydrochloride Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America 1,3-Diaminoguanidine Monohydrochloride Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa 1,3-Diaminoguanidine Monohydrochloride Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa 1,3-Diaminoguanidine Monohydrochloride Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa 1,3-Diaminoguanidine Monohydrochloride Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Sajjan India Limited
12.1.1 Sajjan India Limited Corporation Information
12.1.2 Sajjan India Limited Business Overview
12.1.3 Sajjan India Limited 1,3-Diaminoguanidine Monohydrochloride Product Models, Descriptions and Specifications
12.1.4 Sajjan India Limited 1,3-Diaminoguanidine Monohydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Sajjan India Limited 1,3-Diaminoguanidine Monohydrochloride Sales by Product in 2024
12.1.6 Sajjan India Limited 1,3-Diaminoguanidine Monohydrochloride Sales by Application in 2024
12.1.7 Sajjan India Limited 1,3-Diaminoguanidine Monohydrochloride Sales by Geographic Area in 2024
12.1.8 Sajjan India Limited 1,3-Diaminoguanidine Monohydrochloride SWOT Analysis
12.1.9 Sajjan India Limited Recent Developments
12.2 Shandong Winner Biotech
12.2.1 Shandong Winner Biotech Corporation Information
12.2.2 Shandong Winner Biotech Business Overview
12.2.3 Shandong Winner Biotech 1,3-Diaminoguanidine Monohydrochloride Product Models, Descriptions and Specifications
12.2.4 Shandong Winner Biotech 1,3-Diaminoguanidine Monohydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Shandong Winner Biotech 1,3-Diaminoguanidine Monohydrochloride Sales by Product in 2024
12.2.6 Shandong Winner Biotech 1,3-Diaminoguanidine Monohydrochloride Sales by Application in 2024
12.2.7 Shandong Winner Biotech 1,3-Diaminoguanidine Monohydrochloride Sales by Geographic Area in 2024
12.2.8 Shandong Winner Biotech 1,3-Diaminoguanidine Monohydrochloride SWOT Analysis
12.2.9 Shandong Winner Biotech Recent Developments
12.3 Suzhou Senfida Chemica
12.3.1 Suzhou Senfida Chemica Corporation Information
12.3.2 Suzhou Senfida Chemica Business Overview
12.3.3 Suzhou Senfida Chemica 1,3-Diaminoguanidine Monohydrochloride Product Models, Descriptions and Specifications
12.3.4 Suzhou Senfida Chemica 1,3-Diaminoguanidine Monohydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Suzhou Senfida Chemica 1,3-Diaminoguanidine Monohydrochloride Sales by Product in 2024
12.3.6 Suzhou Senfida Chemica 1,3-Diaminoguanidine Monohydrochloride Sales by Application in 2024
12.3.7 Suzhou Senfida Chemica 1,3-Diaminoguanidine Monohydrochloride Sales by Geographic Area in 2024
12.3.8 Suzhou Senfida Chemica 1,3-Diaminoguanidine Monohydrochloride SWOT Analysis
12.3.9 Suzhou Senfida Chemica Recent Developments
12.4 Jinan Aodekai Pharmaceutical
12.4.1 Jinan Aodekai Pharmaceutical Corporation Information
12.4.2 Jinan Aodekai Pharmaceutical Business Overview
12.4.3 Jinan Aodekai Pharmaceutical 1,3-Diaminoguanidine Monohydrochloride Product Models, Descriptions and Specifications
12.4.4 Jinan Aodekai Pharmaceutical 1,3-Diaminoguanidine Monohydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Jinan Aodekai Pharmaceutical 1,3-Diaminoguanidine Monohydrochloride Sales by Product in 2024
12.4.6 Jinan Aodekai Pharmaceutical 1,3-Diaminoguanidine Monohydrochloride Sales by Application in 2024
12.4.7 Jinan Aodekai Pharmaceutical 1,3-Diaminoguanidine Monohydrochloride Sales by Geographic Area in 2024
12.4.8 Jinan Aodekai Pharmaceutical 1,3-Diaminoguanidine Monohydrochloride SWOT Analysis
12.4.9 Jinan Aodekai Pharmaceutical Recent Developments
12.5 Huaihua Wangda Biotechnology
12.5.1 Huaihua Wangda Biotechnology Corporation Information
12.5.2 Huaihua Wangda Biotechnology Business Overview
12.5.3 Huaihua Wangda Biotechnology 1,3-Diaminoguanidine Monohydrochloride Product Models, Descriptions and Specifications
12.5.4 Huaihua Wangda Biotechnology 1,3-Diaminoguanidine Monohydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Huaihua Wangda Biotechnology 1,3-Diaminoguanidine Monohydrochloride Sales by Product in 2024
12.5.6 Huaihua Wangda Biotechnology 1,3-Diaminoguanidine Monohydrochloride Sales by Application in 2024
12.5.7 Huaihua Wangda Biotechnology 1,3-Diaminoguanidine Monohydrochloride Sales by Geographic Area in 2024
12.5.8 Huaihua Wangda Biotechnology 1,3-Diaminoguanidine Monohydrochloride SWOT Analysis
12.5.9 Huaihua Wangda Biotechnology Recent Developments
12.6 Jinhua Qianjiang Fine Chemical
12.6.1 Jinhua Qianjiang Fine Chemical Corporation Information
12.6.2 Jinhua Qianjiang Fine Chemical Business Overview
12.6.3 Jinhua Qianjiang Fine Chemical 1,3-Diaminoguanidine Monohydrochloride Product Models, Descriptions and Specifications
12.6.4 Jinhua Qianjiang Fine Chemical 1,3-Diaminoguanidine Monohydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Jinhua Qianjiang Fine Chemical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 1,3-Diaminoguanidine Monohydrochloride Industry Chain
13.2 1,3-Diaminoguanidine Monohydrochloride Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 1,3-Diaminoguanidine Monohydrochloride Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 1,3-Diaminoguanidine Monohydrochloride Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 1,3-Diaminoguanidine Monohydrochloride Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global 1,3-Diaminoguanidine Monohydrochloride Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global 1,3-Diaminoguanidine Monohydrochloride Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global 1,3-Diaminoguanidine Monohydrochloride Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global 1,3-Diaminoguanidine Monohydrochloride Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global 1,3-Diaminoguanidine Monohydrochloride Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global 1,3-Diaminoguanidine Monohydrochloride Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global 1,3-Diaminoguanidine Monohydrochloride Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global 1,3-Diaminoguanidine Monohydrochloride Sales by Region (2020-2025) & (Tons)
 Table 8. Global 1,3-Diaminoguanidine Monohydrochloride Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global 1,3-Diaminoguanidine Monohydrochloride Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global 1,3-Diaminoguanidine Monohydrochloride Production by Region (2020-2025) & (Tons)
 Table 12. Global 1,3-Diaminoguanidine Monohydrochloride Production by Region (2026-2031) & (Tons)
 Table 13. Global 1,3-Diaminoguanidine Monohydrochloride Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global 1,3-Diaminoguanidine Monohydrochloride Sales Share by Manufacturers (2020-2025)
 Table 15. Global 1,3-Diaminoguanidine Monohydrochloride Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global 1,3-Diaminoguanidine Monohydrochloride Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global 1,3-Diaminoguanidine Monohydrochloride by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1,3-Diaminoguanidine Monohydrochloride as of 2024)
 Table 19. Global 1,3-Diaminoguanidine Monohydrochloride Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global 1,3-Diaminoguanidine Monohydrochloride Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers 1,3-Diaminoguanidine Monohydrochloride Manufacturing Base and Headquarters
 Table 22. Global 1,3-Diaminoguanidine Monohydrochloride Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global 1,3-Diaminoguanidine Monohydrochloride Sales by Type (2020-2025) & (Tons)
 Table 26. Global 1,3-Diaminoguanidine Monohydrochloride Sales by Type (2026-2031) & (Tons)
 Table 27. Global 1,3-Diaminoguanidine Monohydrochloride Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global 1,3-Diaminoguanidine Monohydrochloride Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global 1,3-Diaminoguanidine Monohydrochloride ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global 1,3-Diaminoguanidine Monohydrochloride Sales by Application (2020-2025) & (Tons)
 Table 32. Global 1,3-Diaminoguanidine Monohydrochloride Sales by Application (2026-2031) & (Tons)
 Table 33. 1,3-Diaminoguanidine Monohydrochloride High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global 1,3-Diaminoguanidine Monohydrochloride Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global 1,3-Diaminoguanidine Monohydrochloride Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global 1,3-Diaminoguanidine Monohydrochloride ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America 1,3-Diaminoguanidine Monohydrochloride Growth Accelerators and Market Barriers
 Table 40. North America 1,3-Diaminoguanidine Monohydrochloride Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America 1,3-Diaminoguanidine Monohydrochloride Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe 1,3-Diaminoguanidine Monohydrochloride Growth Accelerators and Market Barriers
 Table 43. Europe 1,3-Diaminoguanidine Monohydrochloride Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe 1,3-Diaminoguanidine Monohydrochloride Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Growth Accelerators and Market Barriers
 Table 48. Southeast Asia 1,3-Diaminoguanidine Monohydrochloride Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America 1,3-Diaminoguanidine Monohydrochloride Investment Opportunities and Key Challenges
 Table 50. Central and South America 1,3-Diaminoguanidine Monohydrochloride Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa 1,3-Diaminoguanidine Monohydrochloride Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa 1,3-Diaminoguanidine Monohydrochloride Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Sajjan India Limited Corporation Information
 Table 54. Sajjan India Limited Description and Major Businesses
 Table 55. Sajjan India Limited Product Models, Descriptions and Specifications
 Table 56. Sajjan India Limited Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Sajjan India Limited Sales Value Proportion by Product in 2024
 Table 58. Sajjan India Limited Sales Value Proportion by Application in 2024
 Table 59. Sajjan India Limited Sales Value Proportion by Geographic Area in 2024
 Table 60. Sajjan India Limited 1,3-Diaminoguanidine Monohydrochloride SWOT Analysis
 Table 61. Sajjan India Limited Recent Developments
 Table 62. Shandong Winner Biotech Corporation Information
 Table 63. Shandong Winner Biotech Description and Major Businesses
 Table 64. Shandong Winner Biotech Product Models, Descriptions and Specifications
 Table 65. Shandong Winner Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Shandong Winner Biotech Sales Value Proportion by Product in 2024
 Table 67. Shandong Winner Biotech Sales Value Proportion by Application in 2024
 Table 68. Shandong Winner Biotech Sales Value Proportion by Geographic Area in 2024
 Table 69. Shandong Winner Biotech 1,3-Diaminoguanidine Monohydrochloride SWOT Analysis
 Table 70. Shandong Winner Biotech Recent Developments
 Table 71. Suzhou Senfida Chemica Corporation Information
 Table 72. Suzhou Senfida Chemica Description and Major Businesses
 Table 73. Suzhou Senfida Chemica Product Models, Descriptions and Specifications
 Table 74. Suzhou Senfida Chemica Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Suzhou Senfida Chemica Sales Value Proportion by Product in 2024
 Table 76. Suzhou Senfida Chemica Sales Value Proportion by Application in 2024
 Table 77. Suzhou Senfida Chemica Sales Value Proportion by Geographic Area in 2024
 Table 78. Suzhou Senfida Chemica 1,3-Diaminoguanidine Monohydrochloride SWOT Analysis
 Table 79. Suzhou Senfida Chemica Recent Developments
 Table 80. Jinan Aodekai Pharmaceutical Corporation Information
 Table 81. Jinan Aodekai Pharmaceutical Description and Major Businesses
 Table 82. Jinan Aodekai Pharmaceutical Product Models, Descriptions and Specifications
 Table 83. Jinan Aodekai Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Jinan Aodekai Pharmaceutical Sales Value Proportion by Product in 2024
 Table 85. Jinan Aodekai Pharmaceutical Sales Value Proportion by Application in 2024
 Table 86. Jinan Aodekai Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 87. Jinan Aodekai Pharmaceutical 1,3-Diaminoguanidine Monohydrochloride SWOT Analysis
 Table 88. Jinan Aodekai Pharmaceutical Recent Developments
 Table 89. Huaihua Wangda Biotechnology Corporation Information
 Table 90. Huaihua Wangda Biotechnology Description and Major Businesses
 Table 91. Huaihua Wangda Biotechnology Product Models, Descriptions and Specifications
 Table 92. Huaihua Wangda Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Huaihua Wangda Biotechnology Sales Value Proportion by Product in 2024
 Table 94. Huaihua Wangda Biotechnology Sales Value Proportion by Application in 2024
 Table 95. Huaihua Wangda Biotechnology Sales Value Proportion by Geographic Area in 2024
 Table 96. Huaihua Wangda Biotechnology 1,3-Diaminoguanidine Monohydrochloride SWOT Analysis
 Table 97. Huaihua Wangda Biotechnology Recent Developments
 Table 98. Jinhua Qianjiang Fine Chemical Corporation Information
 Table 99. Jinhua Qianjiang Fine Chemical Description and Major Businesses
 Table 100. Jinhua Qianjiang Fine Chemical Product Models, Descriptions and Specifications
 Table 101. Jinhua Qianjiang Fine Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Jinhua Qianjiang Fine Chemical Recent Developments
 Table 103. Key Raw Materials Distribution
 Table 104. Raw Materials Key Suppliers
 Table 105. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 106. Milestones in Production Technology Evolution
 Table 107. Distributors List
 Table 108. Market Trends and Market Evolution
 Table 109. Market Drivers and Opportunities
 Table 110. Market Challenges, Risks, and Restraints
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources


List of Figures
 Figure 1. 1,3-Diaminoguanidine Monohydrochloride Product Picture
 Figure 2. Global 1,3-Diaminoguanidine Monohydrochloride Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Purity 99% Product Picture
 Figure 4. Purity 98% Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global 1,3-Diaminoguanidine Monohydrochloride Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Pesticide Intermediates
 Figure 8. Pharmaceutical Intermediates
 Figure 9. Others
 Figure 10. 1,3-Diaminoguanidine Monohydrochloride Report Years Considered
 Figure 11. Global 1,3-Diaminoguanidine Monohydrochloride Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 13. Global 1,3-Diaminoguanidine Monohydrochloride Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global 1,3-Diaminoguanidine Monohydrochloride Revenue Market Share by Region (2020-2031)
 Figure 15. Global 1,3-Diaminoguanidine Monohydrochloride Sales (2020-2031) & (Tons)
 Figure 16. Global 1,3-Diaminoguanidine Monohydrochloride Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 17. Global 1,3-Diaminoguanidine Monohydrochloride Sales Market Share by Region (2020-2031)
 Figure 18. Global 1,3-Diaminoguanidine Monohydrochloride Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 19. Global 1,3-Diaminoguanidine Monohydrochloride Production Trend by Region (2020-2031) (Tons)
 Figure 20. Global 1,3-Diaminoguanidine Monohydrochloride Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. 1,3-Diaminoguanidine Monohydrochloride Production Growth Rate in China (2020-2031) & (Tons)
 Figure 23. 1,3-Diaminoguanidine Monohydrochloride Production Growth Rate in India (2020-2031) & (Tons)
 Figure 24. Top 5 and Top 10 Manufacturers 1,3-Diaminoguanidine Monohydrochloride Sales Volume Market Share in 2024
 Figure 25. Global 1,3-Diaminoguanidine Monohydrochloride Revenue Market Share Ranking (2024)
 Figure 26. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 27. Purity 99% Revenue Market Share by Manufacturer in 2024
 Figure 28. Purity 98% Revenue Market Share by Manufacturer in 2024
 Figure 29. Others Revenue Market Share by Manufacturer in 2024
 Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 32. Global 1,3-Diaminoguanidine Monohydrochloride Sales Market Share by Type (2020-2031)
 Figure 33. Global 1,3-Diaminoguanidine Monohydrochloride Revenue Market Share by Type (2020-2031)
 Figure 34. Global 1,3-Diaminoguanidine Monohydrochloride Sales Market Share by Application (2020-2031)
 Figure 35. Global 1,3-Diaminoguanidine Monohydrochloride Revenue Market Share by Application (2020-2031)
 Figure 36. North America 1,3-Diaminoguanidine Monohydrochloride Sales YoY (2020-2031) & (Tons)
 Figure 37. North America 1,3-Diaminoguanidine Monohydrochloride Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. North America Top 5 Manufacturers 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) in 2024
 Figure 39. North America 1,3-Diaminoguanidine Monohydrochloride Sales Volume (Tons) by Type (2020- 2031)
 Figure 40. North America 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 41. North America 1,3-Diaminoguanidine Monohydrochloride Sales Volume (Tons) by Application (2020-2031)
 Figure 42. North America 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. US 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 44. Canada 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 45. Mexico 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 46. Europe 1,3-Diaminoguanidine Monohydrochloride Sales YoY (2020-2031) & (Tons)
 Figure 47. Europe 1,3-Diaminoguanidine Monohydrochloride Revenue YoY (2020-2031) & (US$ Million)
 Figure 48. Europe Top 5 Manufacturers 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) in 2024
 Figure 49. Europe 1,3-Diaminoguanidine Monohydrochloride Sales Volume (Tons) by Type (2020-2031)
 Figure 50. Europe 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 51. Europe 1,3-Diaminoguanidine Monohydrochloride Sales Volume (Tons) by Application (2020-2031)
 Figure 52. Europe 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Germany 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 54. France 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 55. U.K. 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 56. Italy 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 57. Russia 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 58. Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Sales YoY (2020-2031) & (Tons)
 Figure 59. Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific Top 8 Manufacturers 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) in 2024
 Figure 61. Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Sales Volume (Tons) by Type (2020- 2031)
 Figure 62. Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 63. Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Sales Volume (Tons) by Application (2020-2031)
 Figure 64. Asia-Pacific 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 65. Indonesia 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 66. Japan 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 67. South Korea 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 68. China Taiwan 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 69. India 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2031) & (US$ Million)
 Figure 70. Central and South America 1,3-Diaminoguanidine Monohydrochloride Sales YoY (2020-2031) & (Tons)
 Figure 71. Central and South America 1,3-Diaminoguanidine Monohydrochloride Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Central and South America Top 5 Manufacturers 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) in 2024
 Figure 73. Central and South America 1,3-Diaminoguanidine Monohydrochloride Sales Volume (Tons) by Type (2021-2031)
 Figure 74. Central and South America 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Central and South America 1,3-Diaminoguanidine Monohydrochloride Sales Volume (Tons) by Application (2020-2031)
 Figure 76. Central and South America 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. Brazil 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2025) & (US$ Million)
 Figure 78. Argentina 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2025) & (US$ Million)
 Figure 79. Middle East, and Africa 1,3-Diaminoguanidine Monohydrochloride Sales YoY (2020-2031) & (Tons)
 Figure 80. Middle East and Africa 1,3-Diaminoguanidine Monohydrochloride Revenue YoY (2020-2031) & (US$ Million)
 Figure 81. Middle East and Africa Top 5 Manufacturers 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) in 2024
 Figure 82. Middle East and Africa 1,3-Diaminoguanidine Monohydrochloride Sales Volume (Tons) by Type (2021-2031)
 Figure 83. South America 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 84. Middle East and Africa 1,3-Diaminoguanidine Monohydrochloride Sales Volume (Tons) by Application (2020-2031)
 Figure 85. Middle East and Africa 1,3-Diaminoguanidine Monohydrochloride Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 86. GCC Countries 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2025) & (US$ Million)
 Figure 87. Turkey 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2025) & (US$ Million)
 Figure 88. Egypt 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2025) & (US$ Million)
 Figure 89. South Africa 1,3-Diaminoguanidine Monohydrochloride Revenue (2020-2025) & (US$ Million)
 Figure 90. 1,3-Diaminoguanidine Monohydrochloride Industry Chain Mapping
 Figure 91. Regional 1,3-Diaminoguanidine Monohydrochloride Manufacturing Base Distribution (%)
 Figure 92. 1,3-Diaminoguanidine Monohydrochloride Production Process
 Figure 93. Regional 1,3-Diaminoguanidine Monohydrochloride Production Cost Structure
 Figure 94. Channels of Distribution (Direct Vs Distribution)
 Figure 95. Bottom-up and Top-down Approaches for This Report
 Figure 96. Data Triangulation
 Figure 97. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart